Back to REGN
Alpine Fox Capital LLC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$379K
Q3 2026
Peak value
$773K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $772K |
| Q1 2026 | $773K |
| Q2 2026 | $312K |
| Q3 2026 | $379K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $379K | 500 | — | — |
| Q2 2026 | $312K | 500 | — | — |
| Q1 2026 | $773K | 1.0K | — | — |
| Q4 2025 | $772K | 1.0K | — | — |